Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

Source:http://linkedlifedata.com/resource/pubmed/id/19181644

Download in:

View as

General Info

PMID
19181644